Skip to main content
Clinical Trials/NCT06536244
NCT06536244
Withdrawn
Not Applicable

Impact of Perioperative Anesthetic Management on Renal Cancer Progression.

M.D. Anderson Cancer Center1 site in 1 countryStarted: July 31, 2020Last updated:

Overview

Phase
Not Applicable
Status
Withdrawn
Locations
1
Primary Endpoint
Postoperative complications

Overview

Brief Summary

The relationship between perioperative drugs, including preoperative medications, anesthetics, and analgesics, and postoperative outcomes in cancer patients is a complex and evolving field of study. Understanding how those medications might impact outcomes such as pain, acute kidney injury, and recurrence is crucial for optimizing perioperative care in renal cancer patients.

Detailed Description

This retrospective study will investigate the association of perioperative drugs on short and long-term postoperative outcomes in patients undergoing kidney surgeries for renal cell carcinoma.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult Participants (18 years of age or older)
  • Participants having radical or partial nephrectomies with curative intent.

Exclusion Criteria

  • Patients with distant metastatic disease and those with multiple (more than 1) primary tumors at the time of the nephrectomy
  • Participants who had radiofrequency or microwave ablations.

Outcomes

Primary Outcomes

Postoperative complications

Time Frame: 72 hours and 30 days postoperatively

Secondary Outcomes

  • Overall survival(Recurrence-free survival:The length of time from surgery to last seen without recurrence or with recurrent disease.)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials